InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Oruka Therapeutics, Inc.

ORKA Clue Score22
United States Fiscal year ends December CIK 0000907654 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Laura Lee Sandler
15 Sep 2026
Chief Operating Officer
Sell
906
$95.71
$86.71K
Paul T Quinlan
15 Sep 2026
General Counsel
Sell
1,039
$95.71
$99.44K
Lawrence Otto Klein
15 Sep 2026
Chief Executive Officer
Sell
2,452
$95.71
$234.68K
Paul T Quinlan
15 Jun 2026
General Counsel
Sell
733
$69.69
$51.08K
Laura Lee Sandler
15 Jun 2026
Chief Operating Officer
Sell
600
$69.69
$41.81K
Lawrence Otto Klein
15 Jun 2026
Chief Executive Officer
Sell
1,729
$69.69
$120.49K
Paul T Quinlan
16 Mar 2026
General Counsel
Sell
733
$41.30
$30.27K
Laura Lee Sandler
16 Mar 2026
Chief Operating Officer
Sell
600
$41.30
$24.78K
Arjun Agarwal
16 Mar 2026
Senior Vice President, Finance
Sell
395
$41.30
$16.31K
Lawrence Otto Klein
16 Mar 2026
Chief Executive Officer
Sell
1,729
$41.30
$71.41K
Show all 127 transactions →

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 110
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 4,378,602
History held since 2 Oct 2006